
Novo Nordisk A/S (NVO.US) Q4 2025 Earnings Conference Call
Live time Feb 4, 2026 12:00 UTC
Novo Nordisk A/S (NVO.US) Q4 2025 Earnings Conference Call
Earnings Call · 4.8K views · Feb 4 12:00
诺和诺德公司 (NVO.US) 2025 年第四季度业绩电话会
Risk Disclaimer: The content on this page represents the author's personal opinions for general information purposes only and should not be used as a basis for any specific investment, business or commercial decision. It does not represent the position of Longbridge, and the platform makes no guarantees or commitments regarding the authenticity, accuracy or originality of the above content.
Novo Nordisk A/S (NVO.US) Q4 2025 Earnings Conference Call
Earnings Call · 4.8K views · Feb 4 12:00
诺和诺德公司 (NVO.US) 2025 年第四季度业绩电话会
Financial overview
Summary
K
Karsten Munk Knudsen
Executive VP, CFO & Member of the Management Board
D
Dave Moore
EVP U.S. Operations
L
Ludovic Helfgott
Executive VP of Product & Portfolio Strategy and Member of Management Board
M
Maziar Mike Doustdar
President, CEO & Member of the Management Board
M
Martin Holst Lange
EVP of R&D, Chief Scientific Officer and Member of the Management Board
M
Michael Novak
Head of Investor Relations
Announcements
Novo Nordisk AS | (6-K) Report by foreign issuer of material events
Feb 17, 2026 06:10 (ET)
Novo Nordisk AS | (6-K) Report by foreign issuer of material events
Feb 11, 2026 16:09 (ET)
Risk Disclaimer: The content on this page represents the author's personal opinions for general information purposes only and should not be used as a basis for any specific investment, business or commercial decision. It does not represent the position of Longbridge, and the platform makes no guarantees or commitments regarding the authenticity, accuracy or originality of the above content.
